. "Basiliximab"^^ . "Basiliximab"^^ . "BasiliximabPTNCI" . "SimulectBRNCI" . "Basiliximab"^^ . "CHEBI:63583"^^ . "9927MT646M"^^ . "459956"^^ . . . "C52186"^^ . . "SDZ-CHI-621CNNCI" . . "179045-86-4"^^ . "459956"^^ . "FDA"^^ . "BASILIXIMABPTFDA9927MT646M" . "Pharmacologic Substance"^^ . . "C0676831"^^ . . "A recombinant, chimeric, human-murine monoclonal antibody directed against the alpha subunit of the interleukin-2 receptor (IL-2R alpha) with immunosuppressant activity. Basiliximab selectively binds to and blocks IL-2R alpha, expressed on the surface of activated T-lymphocytes, thereby preventing interleukin-2 binding and inhibiting the interleukin-2-mediated activation of lymphocytes.NCI" .